Citi Pharma Limited (PSX:CPHL)
Pakistan
· Delayed Price · Currency is PKR 87.07
-1.50 (-1.69%)
At close: Mar 27, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 20.97 billion as of April 3, 2025. Its market cap has increased by 287.22% in one year.
Market Cap
20.97B
Enterprise Value
21.58B
Revenue
13.19B
Ranking
n/a
PE Ratio
25.50
Stock Price
87.07
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 20.97B, an increase of 193.45%. That is a compound annual growth rate of 33.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2025 | 19.89B | 27.84% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 133.26B |
| Abbott Laboratories (Pakistan) | 107.72B |
| AGP Limited | 53.23B |
| The Searle Company | 50.52B |
| Highnoon Laboratories | 48.62B |
| Shifa International Hospitals | 30.35B |
| Ferozsons Laboratories | 13.40B |
| Otsuka Pakistan | 2.20B |